Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase 2b ... MarketWatch (press release) The late four Phase 1 and three Phase 2 trials assessing the safety and efficacy of AN2728 had been designed to delicacy psoriasis on smaller physical structure surface areas. "AN2728 continues to show promise As a topical treatment for mild-to-moderate plaque-type ... Anacor Pharma Reports Preliminary Results From Phase 2b legal proceeding Of AN2728 RTT tidings all 12 news articles » Link To Article
No comments:
Post a Comment